Vascular Biogenics Ltd.
(NASDAQ : VBLT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.64%148.520.0%$1566.70m
OCGNOcugen, Inc. -3.69%9.650.0%$1123.31m
NVAXNovavax, Inc. -13.64%207.5292.9%$895.73m
AMGNAmgen, Inc. 0.22%227.531.3%$553.08m
VRTXVertex Pharmaceuticals, Inc. 1.43%213.381.9%$524.90m
REGNRegeneron Pharmaceuticals, Inc. -1.20%457.502.7%$521.71m
ILMNIllumina, Inc. -0.22%445.533.5%$519.08m
GILDGilead Sciences, Inc. 1.73%63.541.0%$487.81m
BNGOBionano Genomics, Inc. -1.37%9.710.0%$358.88m
ALXNAlexion Pharmaceuticals, Inc. -0.51%151.192.0%$356.41m
BIIBBiogen, Inc. -0.31%272.401.7%$332.20m
CRSPCRISPR Therapeutics AG 0.12%130.410.6%$309.94m
EXASEXACT Sciences Corp. -1.57%138.0218.4%$258.28m
SGENSeagen Inc. 0.96%154.015.8%$212.51m
VXRTVaxart, Inc. -3.44%7.290.0%$202.05m

Company Profile

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.